By assessing the bioavailability of a drug, the rate and amount of absorption can be determined to provide a basis for the optimal design of the drug
,
Theoretical concerns about cortisol modulation remain largely unsubstantiated in practice
In addition, while a number of the agonists in Table 1 (Families 2-5) have norleucine at R 1 , or an amino acid residue, in the practice of various embodiments of this invention a number of an amino acid residues (D or L) may be used at residue R 1 , including without limitation, tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, norvaline, ornithine, S-benzyl cysteine amino acid residues
Summers, Anne Thorburn, Esra Ogru, Robert Gianello, Woei-Jia Jiang, Frank M
Full Disclaimer Terms Research use only